0.3340SEK-7.99%Mkt Cap: 24.91M SEKP/E: —Last update: 2026-06-01
Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum in Sweden. It offers nicotine chewing gum and nicotine pouches under the NIC-S brand name. The company was incor…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap24.91M SEK
Enterprise Value9.31M SEK
Revenue (TTM)3.86M SEK
Gross Profit-15.04M SEK
Net Income (TTM)-75.14M SEK
Revenue/Share0.0390 SEK
Last Price0.3340 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.17
EV/Revenue2.42
P/S7.02
P/B-1.16
EPS (TTM)-0.81
EPS (Forward)—
52W Range
0.21104% of range3.580
52W High3.580 SEK
52W Low0.2110 SEK
Profitability
Gross Margin-549.22%
Oper. Margin-691.35%
EBITDA Margin0.00%
Profit Margin-2743.30%
ROE320.41%
ROA-909.45%
Growth
Revenue Growth250.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-59.26M SEK
CapEx (TTM)—
FCF Margin-181.97%
FCF Yield-28.17%
Net Debt-17.76M SEK
Net Debt/EBITDA0.32
Balance Sheet
Debt/Equity0.00
Current Ratio0.64
Quick Ratio0.55
Book Value/Sh-0.3140 SEK
Cash/Share0.2380 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.74.59M
Float15.81M
Insiders93.57%
Institutions0.02%
Technical
SMA 500.3510 (-4.8%)
SMA 2001.626 (-79.5%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)61.01K
Avg Vol (10d)94.66K
Technical Indicators
RSI (14)51.2
MACD0.0092
MACD Signal-0.0059
MACD Hist.+0.0151
BB Upper0.4417 SEK
BB Middle0.3256 SEK
BB Lower0.2096 SEK
BB Width71.30%
ATR (14)0.0663 SEK
Vol Ratio (20d)0.44x